Getein Biotech, Inc (603387.SS)
CNY 7.94
(0.13%)
CNY 7.94
(0.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 1.73% |
| 2022 | 1.01 Billion CNY | 17.24% |
| 2021 | 863.9 Million CNY | 24.13% |
| 2020 | 695.94 Million CNY | 113.49% |
| 2019 | 325.98 Million CNY | 74.11% |
| 2018 | 187.22 Million CNY | 57.5% |
| 2017 | 118.87 Million CNY | 30.45% |
| 2016 | 91.12 Million CNY | 53.21% |
| 2015 | 59.47 Million CNY | 44.16% |
| 2014 | 41.25 Million CNY | -41.41% |
| 2013 | 70.42 Million CNY | 43.27% |
| 2012 | 49.15 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 963.61 Million CNY | -6.48% |
| 2024 Q3 | 1.16 Billion CNY | 10.13% |
| 2024 Q2 | 1.06 Billion CNY | 10.15% |
| 2023 Q1 | 892.25 Million CNY | -11.91% |
| 2023 FY | 1.03 Billion CNY | 1.73% |
| 2023 Q3 | 1.08 Billion CNY | 7.66% |
| 2023 Q2 | 1.01 Billion CNY | 13.31% |
| 2023 Q4 | 1.03 Billion CNY | -5.34% |
| 2022 Q3 | 1.01 Billion CNY | 3.93% |
| 2022 Q2 | 974.54 Million CNY | -8.33% |
| 2022 FY | 1.01 Billion CNY | 17.24% |
| 2022 Q1 | 1.06 Billion CNY | 23.05% |
| 2022 Q4 | 1.01 Billion CNY | 0.0% |
| 2021 Q3 | 607.39 Million CNY | -13.73% |
| 2021 Q2 | 704.09 Million CNY | 2.72% |
| 2021 Q1 | 685.42 Million CNY | -1.51% |
| 2021 Q4 | 863.9 Million CNY | 42.23% |
| 2021 FY | 863.9 Million CNY | 24.13% |
| 2020 Q1 | 506.77 Million CNY | 55.46% |
| 2020 Q2 | 501.2 Million CNY | -1.1% |
| 2020 Q4 | 695.94 Million CNY | 30.37% |
| 2020 Q3 | 533.84 Million CNY | 6.51% |
| 2020 FY | 695.94 Million CNY | 113.49% |
| 2019 Q2 | 217.65 Million CNY | 12.09% |
| 2019 FY | 325.98 Million CNY | 74.11% |
| 2019 Q4 | 325.98 Million CNY | 73.14% |
| 2019 Q3 | 188.27 Million CNY | -13.5% |
| 2019 Q1 | 194.17 Million CNY | 3.71% |
| 2018 Q3 | 146.15 Million CNY | 13.83% |
| 2018 FY | 187.22 Million CNY | 57.5% |
| 2018 Q4 | 187.22 Million CNY | 28.1% |
| 2018 Q2 | 128.4 Million CNY | 7.77% |
| 2018 Q1 | 119.14 Million CNY | 0.22% |
| 2017 Q1 | 66.95 Million CNY | -26.52% |
| 2017 Q3 | 84.89 Million CNY | 17.17% |
| 2017 Q4 | 118.87 Million CNY | 40.03% |
| 2017 FY | 118.87 Million CNY | 30.45% |
| 2017 Q2 | 72.45 Million CNY | 8.21% |
| 2016 Q4 | 91.12 Million CNY | 0.0% |
| 2016 FY | 91.12 Million CNY | 53.21% |
| 2015 FY | 59.47 Million CNY | 44.16% |
| 2015 Q1 | 25.44 Million CNY | 0.0% |
| 2014 FY | 41.25 Million CNY | -41.41% |
| 2013 FY | 70.42 Million CNY | 43.27% |
| 2012 FY | 49.15 Million CNY | 0.0% |